Lymphoma
📧 Sign up to get email alerts when something new happens for Lymphoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2009-07-14Clinical Trial Update: Study of Oral CNF2024 (BIIB021) in Advanced Solid Tumors [Phase 1]
A Phase 1 study of oral CNF2024 (BIIB021) in advanced solid tumors and lymphoma has completed.
-
CLINICAL_TRIALS trial_result · 2009-05-11Clinical Trial Update: Chemotherapy Related Anemia in Patients With Non-Myeloid Malignancies [Phase 2]
Phase 2 clinical trial update examining chemotherapy-related anemia in patients with non-myeloid malignancies has been completed.
-
CLINICAL_TRIALS trial_result · 2009-03-30Clinical Trial Update: Study of Rasburicase as Treatment or Prevention of Hyperuricemia Associated With Tumor Lysis Syndrome in Patients With Relapsed or Refractory Lymphoma, Leukemia, or Solid Tumor Malignancy [Phase 4]
Phase 4 study evaluating rasburicase for treatment or prevention of hyperuricemia associated with tumor lysis syndrome in patients with rela…
-
CLINICAL_TRIALS trial_result · 2009-03-17Clinical Trial Update: Assessing Antibody Responsiveness to Hepatitis B Vaccine in Aged Lymphoma Patients Undergoing Treatment With Rituximab [NA]
A clinical trial update assessing the antibody response to the Hepatitis B vaccine in older lymphoma patients undergoing rituximab therapy.
-
CLINICAL_TRIALS trial_result · 2009-02-13Clinical Trial Update: Chemotherapy With CD133+ Select Autologous Hematopoietic Stem Cells for Children With Solid Tumors and Lymphomas [NA]
Completed clinical trial evaluating CD133+ selected autologous hematopoietic stem cell chemotherapy in children with solid tumors and lympho…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2009-02-09Clinical Trial Update: Combination Chemotherapy With or Without Idarubicin and Peripheral Stem Cell Transplantation in Treating Patients With Leukemia or Myelodysplastic Syndrome [Phase 3]
This is a Phase 3 trial evaluating combination chemotherapy with or without idarubicin followed by peripheral stem cell transplantation in p…
-
CLINICAL_TRIALS trial_result · 2008-12-30Clinical Trial Update: Feasibility and Efficacy Study of Conditioning Regimen for Allogeneic Hematopoietic Cell Transplantation (HCT) With Fludarabine, Busulfan, and Total Body Irradiation (TBI) [Phase 2]
Phase 2 feasibility and efficacy study of a conditioning regimen using fludarabine, busulfan, and total body irradiation before allogeneic h…
-
CLINICAL_TRIALS trial_result · 2008-12-04Clinical Trial Update: STA-5312 Administered on Alternate Weekdays Every Two Weeks to Patients With Hematologic Malignancies and Patients With Solid Tumors [Phase 1]
Phase 1 clinical trial update for STA-5312 administered on alternate weekdays every two weeks in patients with hematologic malignancies and …
-
CLINICAL_TRIALS trial_result · 2008-10-13Clinical Trial Update: Dose-Escalating Study Of SB-485232 Administered Intravenously Every 28 Days To Adults With Solid Tumors Or Lymphomas [Phase 1]
A Phase 1 dose-escalation study of SB-485232 given intravenously every 28 days in adults with solid tumors or lymphomas has completed.
-
CLINICAL_TRIALS trial_result · 2008-09-22Clinical Trial Update: Pilot Study Combining Temozolomide, Oncovin, Camptosar and Oral Antibiotic in Children and Adolescents With Recurrent Malignancy [Phase 1]
A Phase 1 pilot study evaluated a four-drug combination of temozolomide, vincristine (Oncovin), irinotecan (Camptosar), and an oral antibiot…
-
CLINICAL_TRIALS trial_result · 2008-05-20Clinical Trial Update: A Study Evaluating IV Oncaspar® and IV Gemzar® in the Treatment of Solid Tumors and Lymphoma [Phase 1]
A Phase 1 trial evaluated intravenous Oncaspar (pegaspargase) and intravenous Gemzar (gemcitabine) in patients with solid tumors and lymphom…
-
CLINICAL_TRIALS trial_result · 2008-03-04Clinical Trial Update: Phase I Study of Intrathecal Topotecan [Phase 1]
Phase I study evaluating intrathecal topotecan for leukemia, lymphoma, and meningeal neoplasms has completed.
-
CLINICAL_TRIALS trial_result · 2008-03-04Clinical Trial Update: A Phase I Trial of Continuous Infusion UCN-01 in Patients With Refractory Neoplasms [Phase 1]
This is a Phase I trial update evaluating continuous infusion of UCN-01 in patients with refractory neoplasms, with the study status indicat…
-
CLINICAL_TRIALS trial_result · 2008-03-04Clinical Trial Update: Feasibility Study of Interleukin 1-Alpha With Ifosfamide, CBDCA, and Etoposide With Autologous Bone Marrow Transplant in Metastatic Carcinoma and Lymphoma [Phase 1]
Phase 1 feasibility study evaluating interleukin-1 alpha in combination with Ifosfamide, Carboplatin, and Etoposide with autologous bone mar…
-
CLINICAL_TRIALS trial_result · 2008-03-04Clinical Trial Update: HLA-Mismatched Peripheral Blood Mobilized Hematopoietic Precursor Cell Transplantation for Hematological Malignancies [Phase 1]
Phase 1 clinical trial evaluating HLA-mismatched peripheral blood stem cell transplantation for hematologic malignancies has completed.
-
CLINICAL_TRIALS trial_result · 2008-03-04Clinical Trial Update: A Phase I Study of Oral COL-3 (NSC-683551), a Matrix Metalloproteinase Inhibitor, in Patients With Refractory Metastatic Cancer [Phase 1]
A completed Phase I study of oral COL-3 (NSC-683551), an matrix metalloproteinase inhibitor, in patients with refractory metastatic cancer, …
-
CLINICAL_TRIALS trial_result · 2008-03-04Clinical Trial Update: A Phase I Study of Infusional Paclitaxel With the P-Glycoprotein Antagonist PSC 833 [Phase 1]
Phase I study of infusional paclitaxel combined with the P-glycoprotein antagonist PSC 833 (valspodar) in patients with various cancers; the…
-
CLINICAL_TRIALS trial_result · 2008-03-04Clinical Trial Update: In Vitro Studies of Immunological and Stem Cell Function in Peripheral Blood Mononuclear Cells in Patients
A completed clinical trial update detailing in vitro investigations of immunological and stem cell function in peripheral blood mononuclear …
-
CLINICAL_TRIALS trial_result · 2008-02-28Clinical Trial Update: Pegfilgrastim PBPC Mobilization Study [Phase 2]
Completed Phase 2 clinical trial sponsored by Amgen evaluating pegfilgrastim for peripheral blood progenitor cell mobilization in patients w…
-
CLINICAL_TRIALS trial_result · 2008-02-08Clinical Trial Update: Tacrolimus and MMF as Post Grafting Immunosuppression After Conditioning With Flu TBI for HLA Matched Family Donor [Phase 2]
Phase 2 clinical trial evaluating tacrolimus and mycophenolate mofetil as post-grafting immunosuppression after conditioning with Flu TBI in…
-
CLINICAL_TRIALS trial_result · 2007-11-01Clinical Trial Update: Treatment of Disseminated High Grade Lymphoma [Phase 2, Phase 3]
This clinical trial update summarizes the completion of Phase 2 and Phase 3 studies evaluating treatment for disseminated high-grade lymphom…
-
CLINICAL_TRIALS trial_result · 2007-10-10Clinical Trial Update: Study Comparing the Safety and Efficacy of Piperacillin/Tazobactam to Cefepime in Patients With Hematologic Malignancy or Lymphoma [Phase 3]
A Phase 3 trial comparing safety and efficacy of piperacillin/tazobactam versus cefepime in patients with hematologic neoplasms or lymphoma …
-
CLINICAL_TRIALS trial_result · 2007-09-11Clinical Trial Update: Study of CS-1008 in Patients With Advanced Solid Malignancies and Lymphomas (Without Leukemic Component) [Phase 1]
A Phase 1 study of CS-1008 in patients with advanced solid malignancies and lymphomas (without leukemic components) has completed.
-
CLINICAL_TRIALS trial_result · 2007-08-17Clinical Trial Update: Dose-Dense Therapy in Aggressive Lymphoma
Clinical trial update indicates the dose-dense therapy study for aggressive lymphoma is no longer available.
-
CLINICAL_TRIALS trial_result · 2007-06-14Clinical Trial Update: Study to Evaluate MEDI-507 in Patients With CD2-Positive Lymphoma/Leukemia [Phase 1]
A Phase 1 study evaluating MEDI-507 in CD2-positive lymphoma and leukemia has been terminated.